DR. MICHAEL EDWIN KAFRISSEN, M.D.
Osteopathic Medicine in Raritan, NJ

License number
New Jersey MD017180E
Category
Osteopathic Medicine
Type
General Practice
Address
Address 2
1000 Rte, Raritan, NJ 08869
PO Box 165, Gladstone, NJ 07934
Phone
(908) 704-4609
(908) 218-0460 (Fax)

Professional information

Michael E Kafrissen Photo 1

Dr. Michael E Kafrissen, Philadelphia PA - MD (Doctor of Medicine)

Specialties:
Epidemiology, Obstetrics & Gynecology
Address:
1800 John F Kennedy Blvd STE 1402, Philadelphia 19103
1000 Us Highway 202, Raritan 08869
(908) 704-4609 (Phone), (908) 218-0460 (Fax)
Languages:
English
Education:
Medical School
Temple University
Graduated: 1974


Michael Edwin Kafrissen Photo 2

Michael Edwin Kafrissen, Raritan NJ

Specialties:
Family Physician
Address:
1000 Us Highway 202, Raritan, NJ 08869


Michael Kafrissen Photo 3

Combination Progestin Oral Contraceptive Regimen

US Patent:
6797282, Sep 28, 2004
Filed:
Apr 12, 2001
Appl. No.:
09/833439
Inventors:
Michael Kafrissen - Gladstone NJ
Haya Taitel - Gladstone NJ
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 920
US Classification:
424464, 514843, 514178, 514182, 514170, 424451
Abstract:
An oral contraception regimen which comprises sequentially administering two or more progestational agents exhibiting different effects on the human endometrium in combination with an estrogen. The invention is also directed to an extended use oral contraception regimen comprising the sequential administration of two or more progestational agents in combination with an estrogen.


Michael Kafrissen Photo 4

Combination Progestin Oral Contraceptive Regimen

US Patent:
6251956, Jun 26, 2001
Filed:
Aug 20, 1998
Appl. No.:
9/137401
Inventors:
Michael Kafrissen - Gladstone NJ
Haya Taitel - Gladstone NJ
Assignee:
Ortho Pharmaceutical Corporation - Raritan NJ
International Classification:
A61P 1818, A61K 31565, A61K 31567
US Classification:
514843
Abstract:
An oral contraception regimen which comprises sequentially administering two or more progestational agents exhibiting different effects on the human endometrium in combination with an estrogen. The invention is also directed to an extended use oral contraception regimen comprising the sequential administration of two or more progestational agents in combination with an estrogen.


Michael Kafrissen Photo 5

Pharmaceutical Methods Of Delivering Folic Acid

US Patent:
6190693, Feb 20, 2001
Filed:
Apr 16, 1999
Appl. No.:
9/292027
Inventors:
Michael E. Kafrissen - Gladstone NJ
Godfrey Oakley - Atlanta GA
Assignee:
Ortho-McNeil Pharamceutical, Inc. - Raritan NJ
International Classification:
A61K 948, A61K 920
US Classification:
424451
Abstract:
This invention provides folic acid-containing pharmaceutical compositions comprising either an oral contraceptive or a hormone replacement composition. This invention also provides methods of administering folic acid to a subject using the instant pharmaceutical compositions. Finally, this invention provides a drug delivery system useful for administering the instant pharmaceutical compositions.


Michael Kafrissen Photo 6

Folic Acid-Containing Pharmaceutical Compositions, And Related Methods And Delivery Systems

US Patent:
2006028, Dec 14, 2006
Filed:
Aug 23, 2006
Appl. No.:
11/466504
Inventors:
Michael Kafrissen - Gladstone NJ, US
Godfrey Oakley - Atlanta GA, US
International Classification:
A61K 31/56, A61K 31/525
US Classification:
514171000, 514251000
Abstract:
This invention provides folic acid-containing pharmaceutical compositions comprising either an oral contraceptive or a hormone replacement composition. This invention also provides methods of administering folic acid to a subject using the instant pharmaceutical compositions. Finally, this invention provides a drug delivery system useful for administering the instant pharmaceutical compositions.